DNDN - Sector: Healthcare---Industry: Biotechnology & Drugs

[Melf Elf]

The 34/55 RSIs are at Synchronicity.  The 55/89RSI chart, next sequentially, looks similar to this one/  They're also at Synchronicity. 

[Melf Elf]

The 34/55 RSIs are at Synchronicity.  The 55/89RSI chart, next sequentially, looks similar to this one. They're also at Synchronicity. 

Last Thursday, we got the bounce higher out of Synchronicity in both of these RSIs.  The 89/144 RSIs have been bullish since late June.  Yesterday, the fastest 13/21 RSI also bounced higher out of Bullish Synchronicity.  So, as far as all of those sequential RSIs are concerned, they are "in gear" for a rally.

All that we need now is for PRICE to move up, confirming the bullish technicals. 

MACD also is looking good.  I'll post that chart next. 

[Melf Elf]

It was "gut check" time last Wednesday, when DNDN when back below the Bullish Falling Wedge breakout, accompanied by MACD turning down from zero.  I was thinking then that we were headed back to the 4.00, and that I'd have to settle for a break even, after being long for three months.



Instead, DNDN bounced back out of the Bullish Falling Wedge, and MACD looks much better.  We aren't out of the woods just yet, but....

Whew! (We need a sweating face on the toolbar). 

I'll post the price chart next.

[Melf Elf]

Last Thursday, DNDN rallied back above the Bullish Falling Wedge.

Friday, it came back down and re-tested the top of the Bullish Falling Wedge, re-validated it by holding within two cents above it.

Monday, a rally.

The technicals look good.  We now need to knock out 4.68-4.78 near-term resistance:

4.683 - The purple down trendline

4.735 - The declining 200 DMA

4.78 - The July 26 high

[Melf Elf]

The technicals look good.  We now need to knock out 4.68-4.78 near-term resistance:
4.683 - The purple down trendline

4.735 - The declining 200 DMA

4.78 - The July 26 high

As The Scotsman said, we want to see DNDN get above $5 and stay there, but it's good to see the stock capitalizing on the good technicals, and closing above some of the resistance. 

Yesterday was the first close above the 200DMA since January 11, 2006, which we might view as at least a moral victory of sorts. 

The technicals continue to look good.  MACD is moving higher, above zero, and all of the sequential Fibonacci measures of relative strength are in gear for a rally (see 34/55 RSIs in the next post) .  Now we need for the stock to turn the corner, and move higher.

[Melf Elf]

Breakout in the 34/55 RSIs.

EDIT: Sorry, I posted the wrong chart.  It's been corrected.

[la-onda]

Dendreon "buy"

Friday, August 25, 2006 3:36:49 AM ET
McAdams Wright Ragen

NEW YORK, August 25 (newratings.com)
Analyst Paul C Latta of McAdams Wright Ragen maintains his "buy" rating on Dendreon Corporation (DNR.FSE). The 12-month target price is set to $6.

In a research note published yesterday, the analyst mentions that the company has indicated that it has submitted the clinical and non-clinical portions of BLA for Provenge. Dendreon expects the full BLA filing to be completed during late this year, following the submission of the chemistry, manufacturing and controls (CMC) filing, the analyst adds.

http://www.newratings.com/analyst_news/article_1353866.html

[penny2]

take a look http://www.cticseattle.com/investors_news.htm

[la-onda]

25 days to cover short positions 
Shares Short: 12,873,103

http://www.shortsqueeze.com/index.php?symbol=dndn&submit=Enter

[Melf Elf]

25 days to cover short positions 
Shares Short: 12,873,103

Thanks, Oliver.

DNDN has been hanging onto the bottom of the channel, and now is at the top of the Kumo (Cloud).  If we could get above 5.00 now, especially above the 5.17 high, that would give the shorts reason to cover. 

[Melf Elf]

DNDN has been hanging onto the bottom of the channel, and now is at the top of the Kumo (Cloud).

Oliver,

DNDN closed below the channel on Thursday, and I missed getting stopped out on Friday by a single penny.  I was tempted to sell at the close and be done with it, since I've been holding for 4 months,  but DNDN finished on a possible Bullish Hammer off the bottom of the Kumo (Cloud), so I'll go ahead and play it out, with the stop at 4.39.

Darned annoying, though.   

If we could get above 5.00 now, especially above the 5.17 high, that would give the shorts reason to cover. 

Should we pay some analysts to upgrade it, to get those shorts to cover?    

[la-onda]

Hi MelfElf,
I will wait for any positiv price action next week!
Hope the conferences will help us!
Hope that our patience will be rewarded
cheers
Oliver


SEP 26

Cambridge Healthtech Institute, Baculovirus Technology, September 26
The Production of Antigen PA2024 with BEVS for Provenge (sipuleucel-T), a Novel Immunotherapy against Prostate Cancer
Gilles Lefebvre, Ph.D., Senior Process Development Engineer, Dendreon Corporation
http://www.healthtech.com/2006/BCV/day2.asp


SEP 27

The UBS 2006 Life Sciences Conference at the Grand Hyatt in New York also lists DNDN (Gold) presenting at 1:30 on Wednesday September 27. http://www.ibb.ubs.com/Conferences/pdfs/Preliminary%20Life%20Science%20Agenda%209-16-06.pdf


SEP 28-30

New England Section of the American Urology Association, September 28-30, 2006
Improved Survival With Sipuleucel-T (Apc8015) in Men with Advanced Prostate Cancer
Karim J. Hamawy, MD1, John Libertino, MD,Mark Frohlich, MD2.
http://www.neaua.org/abstracts/2006/P3.cgi

[Melf Elf]

Oliver,

I need some good news at those conferences, so that they quit flirting with my 4.39 stop. 

Yesterday's low: 4.42.   

[Melf Elf]

Oliver,
I need some good news at those conferences, so that they quit flirting with my 4.39 stop. 

Stopped it out at 4.39.   Gain: 8.1%

[la-onda]

not much price action after the 3 presentations hold on conferences....

more patience from my side will hopefully rewarded